Inovalon Mergers and Acquisitions Presentation Deck

Greater Market Addressability The combination of Inovalon and ABILITY is expected to be highly complementary, expanding the addressability of our market opportunity. INOV & ABILITY Presentation (3.7.18) v1.0.0 Payers $17.3bn Current Payer Products $16.3bn Pharma/Life Sciences $51.4bn Current Pharma/Life Sciences Products $7.0bn 2018 Providers $40.1bn Current Providers Products $6.8bn Note: Gartner, IDC, Research and Markets and Inovalon (with methodology validated by HMA). Consumer $33.2bn Independent industry top-down market spend on software and information technology services in healthcare Bottoms-up application of existing Inovalon capabilities to respective market segment opportunity prior to acquisition of ABILITY Expanded addressability of overall market opportunity 12

View entire presentation